First, CD34+/CD38− leukemic stem cells (LSCs) derived from patients with the chronic phase (CP) of chronic myeloid leukemia (CML) expressed CD26 at high levels. This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.